Loading clinical trials...
Loading clinical trials...
Postoperative Heme Oxygenase Induction and Carbon Monoxide Production as a Novel Method to Assess Hepatic Regeneration and Predict Hepatic Related Morbidity After Partial Hepatectomy-1301GCC
Conditions
Interventions
CO Testing Pre/Post Hepatic Resection
ABG Testing Pre/Post Hepatic Resection
+1 more
Locations
1
United States
University of Maryland Baltimore Washington Medical Center
Glen Burnie, Maryland, United States
Start Date
May 7, 2014
Primary Completion Date
March 26, 2024
Completion Date
March 26, 2024
Last Updated
June 21, 2024
NCT06345508
NCT07447050
NCT06440005
NCT06447064
NCT05727787
NCT07295262
Lead Sponsor
University of Maryland, Baltimore
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions